Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.
Saved in:
| Title: | Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies. |
|---|---|
| Authors: | Guerra N; Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, 06510, USA.; Science Research and Technology Scholar, Yale University, New Haven, CT, USA., Hagadorn KA; Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, 06510, USA., Nair M; Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, 06510, USA., Thiam LG; G4-Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal., Williams BG; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom.; Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom., McHugh K; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom.; Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom., Pipini D; Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom., Healer J; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Masendycz P; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Cowman AF; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Draper SJ; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom.; Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, United Kingdom.; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom., Bei AK; Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, 06510, USA.; G4-Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Nov 04. Date of Electronic Publication: 2025 Nov 04. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
